Thierry Soussi
4
Documents
Présentation
-
-
Publications
- 4
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation HotspotsHuman Mutation, 2023, 2023, pp.1-17. ⟨10.1155/2023/4880113⟩
Article dans une revue
hal-04147818v1
|
|
TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemiaAmerican Journal of Hematology, 2022, 97 (4), pp.E159-E162. ⟨10.1002/ajh.26479⟩
Article dans une revue
hal-03557401v1
|
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical PracticeCancer Research, 2017, 77 (6), pp.1250-1260. ⟨10.1158/0008-5472.CAN-16-2179⟩
Article dans une revue
hal-02343459v1
|
|
TP53 mutations are early events in chronic lymphocytic leukemia disease progression and precede evolution to complex karyotypesInternational Journal of Cancer, 2016, 139 (8), pp.1759-1763. ⟨10.1002/ijc.30222⟩
Article dans une revue
hal-02060820v1
|